CGTX · Cognition Therapeutics Inc

$1.01 -0.03 (-2.88%) At close · Aug 14

Market Cap

$96.04M

95.09M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lisa Ricciardi	President and Chief Executive Officer	$651,015	—	$396,456	—	$393,864	$18,300	$1,459,635
Anthony Caggiano	M.D., Ph.D. Chief Medical Officer	$503,010	—	$185,260	—	$221,324	$18,300	$927,894
John Doyle	Chief Financial Officer	$460,575	—	$185,260	—	$202,653	$18,300	$866,788

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lisa Ricciardi	President and Chief Executive Officer	$629,000	—	$445,500	$117,117	$304,436	$18,300	$1,514,353
Anthony Caggiano	M.D., Ph.D. Chief Medical Officer John Doyle Chief Financial Officer	$486,000	—	$376,200	$93,694	$172,072	$18,300	$1,146,266
John Doyle	Chief Financial Officer	$445,000	—	$158,400	$31,231	$156,640	$18,300	$809,571

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lisa Ricciardi	President and Chief Executive Officer	$586,560	—	$453,623	$352,915	$249,288	$18,300	$1,660,686
Anthony Caggiano	M.D., Ph.D. Chief Medical Officer John Doyle Chief Financial Officer	$446,250	—	$200,141	$155,708	$151,725	$18,300	$972,124

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lisa Ricciardi	President and Chief Executive Officer	$550,139	—	—	$220,500	$225,600	$18,300	$1,014,539
James M. O’Brien	Former Chief Financial Officer	$253,372	—	—	$115,568	—	$327,301	$696,241
Anthony Caggiano	M.D., Ph.D. Chief Medical Officer John Doyle Chief Financial Officer	$424,183	—	—	$57,784	$136,000	$18,300	$636,267
Andrew Einhorn	Interim Chief Financial Officer	$319,450	—	—	—	—	—	$319,450

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lisa Ricciardi	President and Chief Executive Officer	$409,354	—	—	$10,664,923	$256,250	$11,600	$11,342,127
Anthony Caggiano	M.D., Ph.D. Chief Medical Officer	$92,788	—	—	$1,590,384	—	$1,319	$1,684,491
James M. O’Brien	Former Chief Financial Officer	$348,769	—	—	$522,787	$155,000	$11,600	$1,038,156

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lisa Ricciardi	President and Chief Executive Officer	$287,385	—	—	$901,904	$79,893	$3,415	$1,272,597
James M. O’Brien	Chief Financial Officer	$340,000	—	—	—	$70,890	$7,323	$418,213
Anthony Caggiano	M.D., Ph.D. Chief Medical Officer	$370,000	—	—	—	—	$11,400	$381,400

Executive changes

Person	Role	Change	Effective	Filed
John Doyle	principal financial officer and principal accounting officer	Appointed	2023-05-15	2023-05-01
John Doyle	Chief Financial Officer	Appointed	2023-05-01	2023-05-01
Andrew Einhorn	Interim Chief Financial Officer	Appointed	2022-08-12	2022-07-27

Key facts CIK 1455365 CUSIP 19243B102 13F (30d) 60 filings 60 filers Visit website Investor relations